Trial intelligence / Profile preview

Sildenafil for severe asthma

IRCT20140518017738N2Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in asthma comparing Sildenafil add-on with Placebo add-on (2 arms). Primary endpoints: Forced expiratory volume in one second, Forced vital capacity and 5 more. Started Oct 2018; status: completed.

02

Drugs

sildenafil
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT20140518017738N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20140518017738N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call